Related Experiment Video
Updated: Mar 18, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.4K
Targeting cancer stem cells with oncolytic virus
11 Department of Hematology, Shanghai General Hospital, Shanghai 200080, China ; 2 Institute of Hematology, the First Afflilated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.
Stem Cell Investigation
|July 1, 2016
Summary
Oncolytic viruses show promise in eradicating cancer stem cells (CSCs), which are resistant to conventional therapies. These viruses offer a novel approach to combatting disease recurrence by targeting CSCs effectively.
Area of Science:
- Oncology
- Virology
- Cancer Biology
Background:
- Cancer stem cells (CSCs) are resistant to conventional therapies and linked to cancer recurrence.
- Oncolytic viruses kill cancer cells through mechanisms distinct from traditional treatments.
- Genetically engineered oncolytic viruses may enhance therapeutic efficacy.
Purpose of the Study:
- To review current data on the efficacy of oncolytic viruses against cancer stem cells.
- To explore the potential of oncolytic viruses as a novel therapeutic strategy for overcoming CSC resistance.
Main Methods:
- Literature review of recent studies on oncolytic viruses and cancer stem cells.
- Analysis of data on the mechanisms of oncolytic virus-mediated CSC eradication.
- Evaluation of the potential for genetically engineered oncolytic viruses.
Main Results:
- Oncolytic viruses demonstrate an ability to overcome CSC resistance mechanisms.
- Several oncolytic viruses have shown potential in eradicating CSCs.
- Genetic engineering can augment the oncolytic effects against CSCs.
Conclusions:
- Oncolytic viruses represent a promising therapeutic avenue for targeting cancer stem cells.
- This approach may help overcome treatment resistance and reduce disease recurrence.
- Further research into engineered oncolytic viruses is warranted for enhanced CSC eradication.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
02:40Cancer Stem Cells and Tumor Maintenance
2.3K
2.3K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.7K
1.7K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K